Home

Lesbarkeit Bitte hinschauen Shampoo sorafenib mechanism Schmetterling ablassen Schreibtisch

Nexavar (Sorafenib)
Nexavar (Sorafenib)

Sorafenib: 10 years after the first pivotal trial | Future Oncology
Sorafenib: 10 years after the first pivotal trial | Future Oncology

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by  inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental  & Clinical Cancer Research | Full Text
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text

Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to  sorafenib and regorafenib - Journal of Hepatology
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology

Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... |  Download Scientific Diagram
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram

Preclinical overview of sorafenib, a multikinase inhibitor that targets  both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular  Cancer Therapeutics
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics

Mechanism of action of sorafenib. Sorafenib inhibits the action of... |  Download Scientific Diagram
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram

Dose-dependent regulation of mitochondrial function and cell death pathway  by sorafenib in liver cancer cells - ScienceDirect
Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells - ScienceDirect

Preclinical overview of sorafenib, a multikinase inhibitor that targets  both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular  Cancer Therapeutics
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics

Evolution in medicinal chemistry of sorafenib derivatives for  hepatocellular carcinoma - ScienceDirect
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect

Figure 4 from New knowledge of the mechanisms of sorafenib resistance in  liver cancer | Semantic Scholar
Figure 4 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar

Pharmacogenetics of the systemic treatment in advanced hepatocellular  carcinoma
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma

Making sorafenib irresistible: <i>In vivo</i> screening for mechanisms of  therapy resistance in hepatocellular carci
Making sorafenib irresistible: <i>In vivo</i> screening for mechanisms of therapy resistance in hepatocellular carci

Sorafenib mechanism of action: tumor proliferation and angiogenesis.... |  Download Scientific Diagram
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram

Targeted therapy in HCC. Mechanisms of resistance to sorafenib in HCC... |  Download Scientific Diagram
Targeted therapy in HCC. Mechanisms of resistance to sorafenib in HCC... | Download Scientific Diagram

Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted  PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to  sorafenib | Journal of Experimental & Clinical Cancer Research | Full Text
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib | Journal of Experimental & Clinical Cancer Research | Full Text

New knowledge of the mechanisms of sorafenib resistance in liver cancer |  Acta Pharmacologica Sinica
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica

16 Management of Locally Advanced Hepatocellular Carcinoma | Radiology Key
16 Management of Locally Advanced Hepatocellular Carcinoma | Radiology Key

An artificial lncRNA targeting multiple miRNAs overcomes sorafenib  resistance in hepatocellular carcinoma cells – lncRNA Blog
An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells – lncRNA Blog

Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib  in hepatocellular carcinoma cells
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells

Scientists discover new transmission mechanism of exosome-mediated sorafenib-resistant  hepatocellular carcinoma cells
Scientists discover new transmission mechanism of exosome-mediated sorafenib-resistant hepatocellular carcinoma cells

Mechanism of action of sorafenib. Sorafenib inhibits the action of... |  Download Scientific Diagram
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram

Downregulation of signal transducer and activator of transcription 3 by  sorafenib: A novel mechanism for hepatocellular carcinoma therapy
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy